PT – 141
Bremelanotide also known as PT-141 has been shown in animal studies to manage the onset of haemorrhagic shock and reperfusion injury. It is thought, it can help in boosting sympathetic outflow to the heart and other organs that may otherwise slow down or stop altogether. It can possibly lessen the kinds of blockages that are typically associated to blood flow restriction to tissues after an ischemic episode. Research of PT-141 has been done exclusively on animal subjects, therefore any test should be done under strictly controlled environment. This product is NOT for human consumption and can be harmful if ingested. These products is intended for use as a research peptide only.